Abiopharma

Tekla World Healthcare Fund is a closed end fund. Its objective is to provide a high level of current income and longterm capital appreciation. Trust expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities and debt securities. Managed Assets means the total assets of the Trust minus the sum of the Trusts accrued liabilities. The Trusts 80% policy may only be changed with 60 days prior notice to the Trusts shareholders. The Trust will concentrate its investments in the healthcare industries. No assurance can be given that the Trust will achieve its investment objective.

Additional info from NASDAQ:
Tekla World Healthcare Fund is a closed end fund. Its objective is to provide a high level of current income and longterm capital appreciation. Trust expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industries including equity securities and debt securities. Managed Assets means the total assets of the Trust minus the sum of the Trusts accrued liabilities. The Trusts 80% policy may only be changed with 60 days prior notice to the Trusts shareholders. The Trust will concentrate its investments in the healthcare industries. No assurance can be given that the Trust will achieve its investment objective.